Peptide record

TPDB25703

Antibacterial Anticancer Antiviral Toxicity standard
36 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB25703
Antibacterial Anticancer Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia AI4AVP DRAMP DRAVP 2.0
standard
No
A 36-aa standard natural multi-activity (Antibacterial, Anticancer, Antiviral, and other sources) peptide sequence curated from Peptipedia, AI4AVP, DRAMP, and other sources, with an available 3D structural model.
Sequence
SLTQINTTLLDLTYEMLSLQQVVKALNESYIDLKEL
Physicochemical Analysis
C185H307N43O61S1
RCGHFPW
L
4141.78
3.92
2
5
17
-3
6.23
0.131
138.06
Mammalian: 1.9 hour Yeast: >20 hour E.coli: >10 hour
2980
71.95
14
Residue Composition
number
1
A
0
R
2
N
2
D
0
C
3
E
3
Q
0
G
0
H
2
I
9
L
2
K
1
M
0
F
0
P
3
S
4
T
0
W
2
Y
2
V
Amino Acid Distribution
A: 1 R: 0 N: 2 D: 2 C: 0 E: 3 Q: 3 G: 0 H: 0 I: 2 L: 9 K: 2 M: 1 F: 0 P: 0 S: 3 T: 4 W: 0 Y: 2 V: 2
Chemical Descriptors
36
C185H307N43O61S1
4141.78
3.92
-3
6.23
0.131
Evidence Records 2 records
Evidence 1 Activity

Activity

Toxicity
Cytotoxic
NA | target cell: HEK293T/ACE2 cells

Target

HEK293T/ACE2 cells

Source & Reference

NA
DBAASP
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. | Nat Commun | 2014
Evidence 2 Activity

Activity

Toxicity
Cytotoxic
NA | target cell: Vero E6 cells

Target

Vero E6 cells

Source & Reference

NA
DBAASP
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. | Nat Commun | 2014